Gregory Gewirtz

Gregory Gewirtz is a Partner in the Linklaters’ Mergers & Acquisitions group in New York.

Gregory’s experience includes a secondment with The Dow Chemical Company’s corporate and financial law department in Midland, Michigan. Gregory has also spent time working in Hong Kong.

Work highlights:

Gregory’s recent deal highlights include advising*:

• Dow Chemical in numerous transactions, including in its US$130bn transaction with DuPont involving the combination of the two companies, the subsequent separation into three public companies and the resulting US$50bn spin-off of Dow Inc.; its US$5bn Reverse Morris Trust transaction with Olin involving Dow’s chlor-alkali and derivatives business; matters relating to its US$17.4bn K-Dow joint venture with PIC; its US$4.8bn strategic ownership restructuring of Dow Corning; its US$1.5bn sale of its MEGlobal joint venture interest to EQUATE; its US$1.63bn sale of Trinseo to Bain Capital; its sale of its global polypropylene business to Braskem; its sale of its interest in Nippon Unicar to the Tonen Group; its sale of its acid copolymers and ionomers business to SK Global Chemical Co.; its sale of its extruded polystyrene foam (XPS) business; and its sale of its German S/A Latex business.
• Celanese in numerous transactions, including in its US$11bn acquisition of the mobility and materials business of DuPont; its restructuring of its Korea Engineering Plastics joint venture with Mitsubishi Gas Chemical; its US$1.575bn divestiture of its interest in its Polyplastics joint venture to Daicel; and its Nutrinova food ingredients joint venture with Mitsui.
• Lanxess in numerous transactions, including in its acquisition of the clean and disinfect business of Chemours; its acquisition of the US phosphorus additives business of Solvay; its acquisition of Emerald Kalama Chemical from American Securities; and its acquisition of the microbial control business of IFF.
• Dover in numerous transactions, including in its acquisition of FW Murphy Production Controls; and its acquisition of Espy Corporation.
• KMG Chemicals in its US$1.6bn sale to Cabot Microelectronics.
• SPX Technologies in its divestiture of subsidiaries holding asbestos liabilities and related assets to a joint venture of Global Risk Capital and Premia Holdings and its related Section 251(g) reorganization.

*The above matters were handled by Gregory prior to joining Linklaters.

Prior to joining Linklaters, Gregory worked as a Counsel in the M&A group of Shearman & Sterling LLP.

Gregory holds a Juris Doctor from the University of Pennsylvania. He has also obtained a Certificate in Business and Public Policy from The Wharton School at The University of Pennsylvania as well as a B.E. in Civil Engineering from The Cooper Union for the Advancement of Science and Art.

Gregory has co-authored the following publications:

• “Changing Its Mind: A Board’s Prerogative?,” The M&A Lawyer, September 2015
• “Dusting Off Appraisal Rights: The Development of a New Investment Strategy,” The M&A Lawyer, April 2014